GHK-Cu Dosing This formulation contains 50 mg of GHK-Cu per vial
Your dose and schedule will be customized based on your needs and lab history (if applicable)
Its long-term safety is simply not yet established, because it remains investigational
KLOW 80mg is a multi-peptide research blend containing four synthetic peptides in one lyophilised vial: GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg)
Research Administration and Dosing Considerations Published research on BPC-157 in animal models has used various administration routes: Intraperitoneal injection: Common in rodent studies but impractical for veterinary application Subcutaneous injection: More relevant to potential veterinary use Intramuscular injection: Studied in some larger animal models Oral administration: Some research suggests oral bioavailability, though data is limited Topical application: Investigated for wound healing applications Dosing in animal studies varies widely (typically reported as g/kg body weight), and optimal dosing for dogs specifically has not been established through controlled veterinary trials
Individuals with digestive issues: Individuals with digestive conditions such as Crohn's disease or celiac disease may have difficulty absorbing enough B12, making supplementation an important solution